Montana State University

Office of Biosafety

Kirk Lubick, M.S., ARO
Biosafety Officer
P.O. Box 173085
Bozeman, MT 59717
Tel. (406) 994-6998
Fax: (406) 994-4790

Kirk.lubick@montana.edu

Elizabeth Nicholas
Committees Coordinator
P.O. Box 173085
Bozeman, MT 59717
Tel. (406) 994-6821
Fax: (406) 994-4790

Nicholas@montana.edu

IBC Chair

Dr. Michael Babcock
Psychology Dept.
304 Traphagen
Tel. (406) 994-5175

mbabcock@montana.edu

Institutional Biosafety Committee

_______________________________________________________________________________________

The Institutional Biosafety Committee (IBC) at MSU was established to ensure that activities with biohazardous material are conducted safely and responsibly. To fulfill this commitment the IBC reviews and monitors all research and teaching activities by faculty, staff and students, that utilize infectious agents, human body fluids or tissues, and recombinant or synthetic nucleic acid molecules. Reviews and monitoring are conducted in accordance with the NIH Guidelines for Research Involving Recombinant DNA or Synthetic Nucleic Acid Molecules (NIH Guidelines) and the Center for Disease Control and Prevention Biosafety in Microbiological and Biomedical Laboratories (BMBL).

If you are unsure if your work requires an IBC protocol, contact the Biosafety Officer or reference the biohazardous material requiring an IBC protocol.  If your work involves the use of recombinant DNA and are unsure what NIH guidelines are applicable please look at the recombinant DNA Classification tool.   To submit an IBC protocol please select one of the following: protocol, modification, or annual renewal.  Applications must be received by the deadline to allow enough time for a pre-biosafety review and review by the committee.  Submission deadlines and meeting dates can be found at meeting dates and deadlines.

IBC approval can only be granted if all personnel have completed the required CITI Biosafety training.  To see what courses are required please look at the Biosafety training matrix.    

IBC approval of recombinant DNA and biohazardous research projects are effective for three years.  PIs must complete an IBC Renewal each year to continue work and after three years the application must be resubmitted and reviewed by the committee.

_______________________________________________________________________________________